MHC class I molecules and KIRs in human history, health and survival

被引:911
作者
Parham, P [1 ]
机构
[1] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nri1570
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MHC class I molecules are ligands for the killer-cell immunoglobulin-like receptors (KIRs), which are expressed by natural killer cells and T cells. The interactions between these molecules contribute to both innate and adaptive immunity. KIRs and MHC class I molecules are encoded by unlinked polymorphic gene families that distinguish all but the most related individuals. Combinations of MHC class I and KIR variants influence resistance to infections, susceptibility to autoimmune diseases and complications of pregnancy, as well as outcome after haematopoietic stem-cell transplantation. Such correlations raise the possibility that interplay between KIR and MHC class I polymorphisms has facilitated human survival in the presence of epidemic infections and has influenced both reproduction and population growth.
引用
收藏
页码:201 / 214
页数:14
相关论文
共 125 条
  • [11] The LILR family: modulators of innate and adaptive immune pathways in health and disease
    Brown, D
    Trowsdale, J
    Allen, R
    [J]. TISSUE ANTIGENS, 2004, 64 (03): : 215 - 225
  • [12] NK3-SPECIFIC NATURAL-KILLER-CELLS ARE SELECTIVELY INHIBITED BY BW4-POSITIVE HLA ALLELES WITH ISOLEUCINE-80
    CELLA, M
    LONGO, A
    FERRARA, GB
    STROMINGER, JL
    COLONNA, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1235 - 1242
  • [13] DNA methylation maintains allele-specific KTR gene expression in human natural killer cells
    Chan, HW
    Kurago, ZB
    Stewart, CA
    Wilson, MJ
    Martin, MP
    Mace, BE
    Carrington, M
    Trowsdale, J
    Lutz, CT
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) : 245 - 255
  • [14] Recognition by gamma/delta T cells
    Chien, YH
    Jores, R
    Crowley, MP
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 511 - 532
  • [15] HLA-C IS THE INHIBITORY LIGAND THAT DETERMINES DOMINANT RESISTANCE TO LYSIS BY NK1-SPECIFIC AND NK2-SPECIFIC NATURAL-KILLER-CELLS
    COLONNA, M
    BORSELLINO, G
    FALCO, M
    FERRARA, GB
    STROMINGER, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) : 12000 - 12004
  • [16] The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia
    Cook, MA
    Milligan, DW
    Fegan, CD
    Darbyshire, PJ
    Mahendra, P
    Craddock, CF
    Moss, PAH
    Briggs, DC
    [J]. BLOOD, 2004, 103 (04) : 1521 - 1526
  • [17] Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants
    Davies, SM
    Ruggieri, L
    DeFor, T
    Wagner, JE
    Weisdorf, DJ
    Miller, JS
    Velardi, A
    Blazar, BR
    [J]. BLOOD, 2002, 100 (10) : 3825 - 3827
  • [18] Genetic divergence of the rhesus macaque major histocompatibility complex
    Daza-Vamenta, R
    Glusman, G
    Rowen, L
    Guthrie, B
    Geraghty, DE
    [J]. GENOME RESEARCH, 2004, 14 (08) : 1501 - +
  • [19] Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation
    Dupont, B
    Hsu, KC
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (05) : 634 - 643
  • [20] Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes
    Epling-Burnette, PK
    Painter, JS
    Chaurasia, P
    Bai, FQ
    Wei, S
    Djeu, JY
    Loughran, TP
    [J]. BLOOD, 2004, 103 (09) : 3431 - 3439